| Understanding nonviral nucleic acid delivery with quantum dot-FRET nanosensors. | |
| | |
MedLine Citation:
|
PMID: 22471720 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nonviral delivery of nucleic acids is a potentially safe and viable therapeutic modality for inherited and acquired diseases. However, current systems have proven too inefficient for widespread clinical translation. The rational design of improved carriers depends on a quantitative, mechanistic understanding of the rate-limiting barriers to efficient intracellular delivery. Separation of the nucleic acid from the carrier is one of the barriers, which may be analyzed by Förster resonance energy transfer (FRET), a mechanism used to detect interactions between fluorescently labeled molecules. When applied to the molecular components of polymer or lipid-based nanocomplexes, FRET provides information on their complexation status, uptake, release and degradation. Recently, the design of FRET systems incorporating quantum dots as energy donors has led to improved signal stability, allowing prolonged measurements, as well as increased sensitivity, enabling direct detection and the potential for multiplexing. The union of quantum dots and FRET is providing new insights into the mechanisms of nonviral nucleic acid delivery through convergent characterization of delivery barriers, and has the potential to accelerate the design of improved carriers to realize the potential of nucleic acid therapeutics and gene medicine. |
| | |
Authors:
|
Christopher L Grigsby; Yi-Ping Ho; Kam W Leong |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review |
Journal Detail:
|
Title: Nanomedicine (London, England) Volume: 7 ISSN: 1748-6963 ISO Abbreviation: Nanomedicine (Lond) Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-04-04 Completed Date: 2012-07-23 Revised Date: 2013-04-08 |
Medline Journal Info:
|
Nlm Unique ID: 101278111 Medline TA: Nanomedicine (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 565-77 Citation Subset: IM |
Affiliation:
|
Department of Biomedical Engineering, Duke University, Durham, NC, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Fluorescence Resonance Energy Transfer
/
methods* Genetic Vectors / chemistry* Nucleic Acids / administration & dosage, chemistry* Quantum Dots* |
| Grant Support | |
ID/Acronym/Agency:
|
HL89764/HL/NHLBI NIH HHS; R01 AI096305/AI/NIAID NIH HHS; R01 HL089764/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Nucleic Acids |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: In vitro targeted imaging and delivery of camptothecin using cetuximab-conjugated multifunctional PL...
Next Document: Nanoparticles and spermatogenesis: how do nanoparticles affect spermatogenesis and penetrate the blo...